The aggregation of amyloid-β peptides into protein fibres is one of the main neuropathological features of Alzheimer’s disease (AD). While imaging of amyloid-β aggregate morphology in vitro is extremely important for understanding AD pathology and development of aggregation inhibitors, unfortunately, potentially highly toxic early aggregates are difficult to observe by current electron microscopy and atomic force microscopy (AFM) methods due to low contrast and variability of peptide attachment to the substrate. Here, we use poly-L-Lysine (PLL) surface that captures all protein components from monomers to fully formed fibres, followed by nanomechanical mapping via Ultrasonic Force Microscopy (UFM), which marries high spatial resolution and nanomechanical contrast with non-destructive nature of tapping mode AFM. For the main putative AD pathogenic component, Aβ1-42, the PLL-UFM approach reveals the morphology of oligomers, protofibrils and mature fibres, and finds that a fraction of small oligomers is still present at later stages of fibril assembly.